Skip to main content

ShiraTronics receives Breakthrough Device designation from FDA for migraine tech

ShiraTronics has largely flown under the radar, but the firm had one of 2019's largest venture capital raises in a $33 million Series A round.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.